Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QRICH1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | COMP | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
mRNA | LMNA | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
mRNA | KRTAP1-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | SNX19 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | SNX33 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | ZSCAN29 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | RNF219 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | SLC12A4 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | PDCD11 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |